Evidence map›Paper›PMID 25118691›Full record

ArticlePloS one2014

An appraisal of female sex work in Nigeria--implications for designing and scaling up HIV prevention programmes.

Akudo Ikpeazu, Amaka Momah-Haruna, Baba Madu Mari, Laura H Thompson, Kayode Ogungbemi, Uduak Daniel, Hafsatu Aboki, Shajy Isac, Marelize Gorgens, Elizabeth Mziray and 5 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Spectrum of female commercial sex work in Bangui, Central African Republic.SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance · 2017
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Akudo IkpeazuNational Agency for the Control of AIDS, Abuja, Nigeria.
Amaka Momah-HarunaCentre for Global Public Health, Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada.
Baba Madu MariCentre for Global Public Health, Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada.
Laura H ThompsonCentre for Global Public Health, Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada.
Kayode OgungbemiNational Agency for the Control of AIDS, Abuja, Nigeria.
Uduak DanielNational Agency for the Control of AIDS, Abuja, Nigeria.
Hafsatu AbokiNational Agency for the Control of AIDS, Abuja, Nigeria.
Shajy IsacCentre for Global Public Health, Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada.
Marelize GorgensWorld Bank, Washington, DC, United States of America.
Elizabeth MzirayWorld Bank, Washington, DC, United States of America.
Ndella NjieWorld Bank, Washington, DC, United States of America.
Francisca Ayodeji AkalaWorld Bank, Washington, DC, United States of America.
Faran EmmanuelCentre for Global Public Health, Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada.
Willis Omondi OdekCentre for Global Public Health, Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada.
James F BlanchardCentre for Global Public Health, Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe HIV epidemic in Nigeria is complex with diverse factors driving the epidemic. Accordingly, Nigeria's National Agency for the Control of AIDS is coordinating a large-scale initiative to conduct HIV epidemic appraisals across all states. These appraisals will help to better characterize the drivers of the epidemic and ensure that the HIV prevention programmes match the local epidemic context, with resources allocated to interventions that have the greatest impact locally. Currently, the mapping and size estimation of Female Sex Workers (FSWs)--a major component of the appraisal has been completed in seven states. These states are using the data generated to plan, prioritize and scale-up sub-national HIV prevention programmes. METHODOLOGY: It involved a two-level process of identifying and validating locations where FSWs solicit and/or meet clients ("hotspots"). In the first level, secondary key informants were interviewed to collect information about the geographic location and description of the hotspots. For the second level, FSWs were interviewed at each hotspot and information on population size estimates, typologies and operational dynamics of the FSWs were collected.

resultsAcross the seven states, a total of 17,266 secondary key informants and 5,732 FSWs were interviewed. 10,233 hotspots were identified with an estimated 126,489 FSWs ranging from 5,920 in Anambra to 46,691 in Lagos. The most common hotspots were bars/nightclubs (30%), hotels/lodges (29.6%), streets (16.6%), and brothels (14.6%). Furthermore, the population density of FSWs (per thousand adult men) across the states ranged from 2 in Anambra to 17 in the Federal Capital Territory.

conclusionFSW populations in Nigeria are large and diverse, with substantial differences between and within states. Improved understanding of the location, population size, density, organizational typologies and clients of sex work has informed and is central to Nigeria's planning process for scaling up focused HIV prevention programmes.

Indexed as

National Health ProgramsSex WorkersFemaleHIV InfectionsHumansNigeria

Identifiers

PMID25118691
PMCPMC4131880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.